艾勒朗制药(ALRN)股吧_艾勒朗制药怎么样_分析讨论社区

列表
摘要

发新帖

发表新帖
问董秘
发起斗股

阅读	评论	标题	作者	最后更新
277	0	Current report, items 2.02 and 9.01	艾勒朗制药资讯	11-15 06:32
278	0	Quarterly report [Sections 13 or 15(d)]	艾勒朗制药资讯	11-15 05:30
423	0	[Amend] Statement of Beneficial Ownership by Certain Investors	艾勒朗制药资讯	11-06 09:52
651	0	Statement of changes in beneficial ownership of securities	艾勒朗制药资讯	08-23 09:13
662	0	Statement of changes in beneficial ownership of securities	艾勒朗制药资讯	08-23 07:57
662	0	Statement of changes in beneficial ownership of securities	艾勒朗制药资讯	08-23 04:26
660	0	Statement of changes in beneficial ownership of securities	艾勒朗制药资讯	08-23 04:24
662	0	Statement of changes in beneficial ownership of securities	艾勒朗制药资讯	08-23 04:23
671	0	Current report, items 5.07 and 9.01	艾勒朗制药资讯	08-22 05:11
707	0	Current report, items 2.02 and 9.01	艾勒朗制药资讯	08-15 05:41
710	0	Quarterly report [Sections 13 or 15(d)]	艾勒朗制药资讯	08-15 05:33
656	0	Current report, items 1.01, 8.01, and 9.01	艾勒朗制药资讯	07-27 06:22
649	0	Prospectus [Rule 424(b)(5)]	艾勒朗制药资讯	07-27 05:51
650	0	Prospectus [Rule 424(b)(5)]	艾勒朗制药资讯	07-27 05:19
464	0	Annual Report to Security Holders	艾勒朗制药资讯	07-09 09:27
468	0	Other definitive proxy statements	艾勒朗制药资讯	07-09 08:48
472	0	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	艾勒朗制药资讯	07-09 08:47
551	0	Statement of changes in beneficial ownership of securities	艾勒朗制药资讯	06-18 07:57
601	0	Statement of changes in beneficial ownership of securities	艾勒朗制药资讯	06-13 06:33
644	0	Statement of changes in beneficial ownership of securities	艾勒朗制药资讯	06-08 07:27
617	0	Current report, items 5.08 and 8.01	艾勒朗制药资讯	06-05 07:22
550	0	Initial statement of beneficial ownership of securities	艾勒朗制药资讯	05-17 03:02
557	0	Current report, item 5.02	艾勒朗制药资讯	05-17 05:08
550	0	Quarterly report [Sections 13 or 15(d)]	艾勒朗制药资讯	05-16 05:46
547	0	Current report, items 2.02 and 9.01	艾勒朗制药资讯	05-16 05:46
548	0	[Amend] Statement of changes in beneficial ownership of securities	艾勒朗制药资讯	05-15 06:12
482	0	Statement of changes in beneficial ownership of securities	艾勒朗制药资讯	05-02 08:02
475	0	Current report, items 1.01, 8.01, and 9.01	艾勒朗制药资讯	05-02 05:40
477	0	Prospectus [Rule 424(b)(5)]	艾勒朗制药资讯	05-02 05:40
469	0	Securities to be offered to employees in employee benefit plans	艾勒朗制药资讯	05-02 05:34
449	0	Filing under Securities Act Rules 163/433 of free writing prospectuses	艾勒朗制药资讯	05-01 09:00
445	0	Current report, items 2.02 and 8.01	艾勒朗制药资讯	05-01 08:52
437	0	Initial statement of beneficial ownership of securities	艾勒朗制药资讯	05-01 07:22
407	0	Report of proposed sale of securities	艾勒朗制药资讯	04-30 05:13
400	0	[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]	艾勒朗制药资讯	04-29 08:38
433	0	[Amend] General statement of acquisition of beneficial ownership	艾勒朗制药资讯	04-17 08:11
435	0	Annual report [Section 13 and 15(d), not S-K Item 405]	艾勒朗制药资讯	04-16 05:39
433	0	Current report, items 2.02 and 9.01	艾勒朗制药资讯	04-16 05:38
432	0	[Amend] Statement of changes in beneficial ownership of securities	艾勒朗制药资讯	04-11 07:05
431	0	[Amend] Statement of changes in beneficial ownership of securities	艾勒朗制药资讯	04-11 07:05
431	0	Initial statement of beneficial ownership of securities	艾勒朗制药资讯	04-03 09:11
451	0	Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KS	艾勒朗制药资讯	04-02 05:26
428	0	Current report, item 5.02	艾勒朗制药资讯	03-29 08:13
393	0	Current report, items 5.02, 7.01, and 9.01	艾勒朗制药资讯	03-15 07:40
429	0	Statement of changes in beneficial ownership of securities	艾勒朗制药资讯	03-07 07:07
425	0	Statement of acquisition of beneficial ownership by individuals	艾勒朗制药资讯	03-06 10:41
443	0	[Amend] General statement of acquisition of beneficial ownership	艾勒朗制药资讯	03-06 06:58
447	0	Current report, items 5.02 and 8.01	艾勒朗制药资讯	03-02 05:42
453	0	Statement of changes in beneficial ownership of securities	艾勒朗制药资讯	03-02 05:23
441	0	Statement of changes in beneficial ownership of securities	艾勒朗制药资讯	03-02 05:16
427	0	Current report, items 5.02, 5.03, 5.07, 8.01, and 9.01	艾勒朗制药资讯	02-29 09:35
479	0	[Amend] Statement of acquisition of beneficial ownership by individuals	艾勒朗制药资讯	02-14 11:44
507	0	Current report, item 5.02	艾勒朗制药资讯	02-13 08:34
446	0	Notice of Effectiveness	艾勒朗制药资讯	02-06 07:59
459	0	[Amend] Statement of acquisition of beneficial ownership by individuals	艾勒朗制药资讯	02-06 02:33
452	0	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	艾勒朗制药资讯	02-01 10:46
438	0	Registration statement under Securities Act of 1933	艾勒朗制药资讯	01-30 07:09
433	0	Securities to be offered to employees in employee benefit plans	艾勒朗制药资讯	01-30 05:59
441	0	Annual Report to Security Holders	艾勒朗制药资讯	01-29 10:48
423	0	Other definitive proxy statements	艾勒朗制药资讯	01-29 10:07
424	0	Current report, items 5.08 and 8.01	艾勒朗制药资讯	01-29 09:37
448	0	Current report, items 8.01 and 9.01	艾勒朗制药资讯	01-25 08:49
468	0	Other preliminary proxy statements	艾勒朗制药资讯	01-20 06:13
466	0	[Amend] Current report, item 9.01	艾勒朗制药资讯	01-12 06:28
484	0	Current report, items 3.01 and 4.01	艾勒朗制药资讯	01-11 05:15
388	0	Statement of changes in beneficial ownership of securities	艾勒朗制药资讯	12-19 07:35
299	2	Statement of changes in beneficial ownership of securities	艾勒朗制药资讯	11-22 06:12
331	0	Notice of Exempt Offering of Securities, item 06b	艾勒朗制药资讯	11-16 11:13
309	0	Statement of acquisition of beneficial ownership by individuals	艾勒朗制药资讯	11-14 07:03
372	0	[Amend] General statement of acquisition of beneficial ownership	艾勒朗制药资讯	11-04 05:16
363	0	Statement of changes in beneficial ownership of securities	艾勒朗制药资讯	11-03 02:56
379	0	Initial statement of beneficial ownership of securities	艾勒朗制药资讯	11-03 02:56
376	0	Initial statement of beneficial ownership of securities	艾勒朗制药资讯	11-03 09:12
390	0	Initial statement of beneficial ownership of securities	艾勒朗制药资讯	11-03 09:11
367	0	Statement of changes in beneficial ownership of securities	艾勒朗制药资讯	11-03 09:11
394	0	Current report, items 1.01, 2.01, 3.02, 4.01, 5.02, 5.03, 7.01, 8.01, and 9.01	艾勒朗制药资讯	11-01 02:52
443	0	Quarterly report [Sections 13 or 15(d)]	艾勒朗制药资讯	10-14 04:21
453	0	Quarterly report [Sections 13 or 15(d)]	艾勒朗制药资讯	08-12 04:52
176	0	Quarterly report [Sections 13 or 15(d)]	艾勒朗制药资讯	05-08 08:10
166	0	[Amend] Annual report [Section 13 and 15(d), not S-K Item 405]	艾勒朗制药资讯	04-28 09:36

emytylist